9:22 AM
Leo Group India
| ||
| Bringing more essential drugs under control a fair policy: CII Economic Times While the industry welcomes this move, it would also be pertinent to note that the proposed policy will expand the span of price control to around 30 per cent of the domestic pharmaceutical market and impact revenues of the industry which is already ... See all stories on this topic » | ||
| Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012 Sacramento Bee "We are very glad that the Company has made some important improvements in the year ended June 30, 2012," stated Qingtai Liu, CEO of Shengtai Pharmaceutical, Inc., "The Company developed a new product, corn germ meal, which can be used as animal ... See all stories on this topic » | ||
| MNCs have 53 percent share in pharmaceutical market: National Assembly ... Business Recorder (blog) Multinational pharmaceutical companies have 53 percent share in Pakistan's pharmaceutical market while national companies are contended with 45 percent share, however, the estimated market growth rate is 19 percent. Joint Secretary Ministry of National ... See all stories on this topic » | ||
| New drug pricing formula to cost Ranbaxy, GSK Dr Reddy's & others Rs 1300 crore Economic Times NEW DELHI: The drug pricing formula recommended by a ministerial panel will erode the revenues of pharmaceutical companies by about 1,300 crore, according to market research firm IMS Health. Among these companies, Ranbaxy, GlaxoSmithKline, ... See all stories on this topic » | ||
| 7 Pharmaceutical Stocks to Buy Now Investorplace.com The grades of seven Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. Novartis (NYSE:NVS) is bettering its rating of C ("hold ... See all stories on this topic » | ||
| Abbott Labs misstated college education of soon-to-be CEO of pharmaceutical ... Washington Post WASHINGTON — Abbott Laboratories said Friday it repeatedly misstated the college education of senior executive Robert Gonzalez, who is soon slated to become CEO of its $18 billion-pharmaceutical spinoff. Company regulatory filings between 2002 and ... See all stories on this topic » | ||
| Par Pharmaceutical Announces Completion Of Acquisition By TPG RTT News (RTTNews) - Par Pharmaceutical Companies, Inc., (PRX:Quote) and TPG said Friday that certain affiliates of TPG have completed the acquisition of Par. As per the deal, Par's stockholders are entitled to receive $50.00 in cash for each share of Par ... See all stories on this topic » | ||
| S&P PHARMACEUTICAL CO., LTD. : Xipei Jiang Was Invited To Participate In ... 4-traders S&P Pharmaceutical Co., Ltd. : Xipei Jiang Was Invited To Participate In Yixing City "steady growth, promote transformation" Symposium. 09/29/2012 | 09:04am US/Eastern. Xipei Jiang Was Invited To Participate In Yixing City "steady growth, promote ... See all stories on this topic » | ||
| Biotech and Pharmaceutical News: Walgreen (NYSE:WAG) Fights to Win Back ... Minyanville.com Biotech and Pharmaceutical News: Walgreen (NYSE:WAG) Fights to Win Back Express Scripts (NASDAQ:ESRX) Customers. By Alec Niedenthal Sep 28, 2012 2:10 pm. Plus, pharmas form a non-profit to expedite trials for new drugs. PRINT · Post Comments ... See all stories on this topic » | ||
|
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment